Immunotherapy: current state of research in breast cancer
Checkpoint inhibitors make headlines with promising new data in cancer treatment on an almost daily basis, especially in melanoma and lung cancer. But what role are they - and other forms of immunotherapy - expected to play in breast cancer and why does progress appear to be slower than for some other tumours?
In the 5th edition of BIG Research in Focus scientific writer Jenny Bryan talks to leading researchers about current understanding of the immune response to breast cancer, ongoing trials of checkpoint inhibitors, and novel approaches to boost T lymphocyte and other immune cell activity.
BIG Research in Focus is a twice a year publication, focusing on a specific topic related to breast cancer research and published by BIG, the largest global research network dedicated solely to breast cancer.
BIG encompasses 55 member groups worldwide, which are breast cancer focused collaborative research groups or data centres.
The communication agency Page in extremis has designed and produced the periodical in close collaboration with the BIG’s Communication team.
Based in Brussels, the communication agency has expertise in institutional and corporate communication.
The multidisciplinary team can help you define and translate the core idea of your organisation into brilliant visual systems.
More information:
http://www.inextremis.be
http://www.inextremisbranding.be
http://www.inextremisdigital.be
